2004
DOI: 10.1016/j.beem.2004.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Potential clinical applications of vasoactive intestinal peptide: a selected update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(11 citation statements)
references
References 114 publications
0
10
0
Order By: Relevance
“…It was additionally proven that intraperitoneal injection of VIP prevented stress-induced gastric ulcer formation by inhibiting mast cell degranulation and preventing lipid peroxidation (Tuncel et al 1998). Due to its anti-inflammatory properties, VIP has been successfully applied as a therapeutic agent in multiple pathologies, such as heart failure, primary pulmonary hypertension, type 2 diabetes, and gastrointestinal motility disorders (Gozes and Furman 2003; Gozes and Furman 2004), and may be a candidate for treatment of various inflammatory processes. Our finding of increased expression of PACAP and VIP in the porcine vagal neurons as a consequence of aspirin-induced gastritis provides convincing evidence of the special role of both peptides in neuronal response to gastric pathology and confirms the pig as a good animal model for a PACAP/VIP anti-inflammatory preclinical study.…”
Section: Discussionmentioning
confidence: 99%
“…It was additionally proven that intraperitoneal injection of VIP prevented stress-induced gastric ulcer formation by inhibiting mast cell degranulation and preventing lipid peroxidation (Tuncel et al 1998). Due to its anti-inflammatory properties, VIP has been successfully applied as a therapeutic agent in multiple pathologies, such as heart failure, primary pulmonary hypertension, type 2 diabetes, and gastrointestinal motility disorders (Gozes and Furman 2003; Gozes and Furman 2004), and may be a candidate for treatment of various inflammatory processes. Our finding of increased expression of PACAP and VIP in the porcine vagal neurons as a consequence of aspirin-induced gastritis provides convincing evidence of the special role of both peptides in neuronal response to gastric pathology and confirms the pig as a good animal model for a PACAP/VIP anti-inflammatory preclinical study.…”
Section: Discussionmentioning
confidence: 99%
“…The VIPR family includes 2 subtypes: VIPR-1 and VIPR-2 (Gozes and Furman, 2004). Both are G protein-coupled receptors that can activate adenylate cyclase.…”
Section: Discussionmentioning
confidence: 99%
“…VIP exerts multiple actions tending to counteract some of the pathways of inflammation and apoptosis and, thus, to promote cell survival. VIP is the major neuropeptide with neurotrophic, neurotransmitter, neuromodulatory, antioxidant, antiinflammatory, and antiapoptotic properties (Said 1996;Said and Dickman 2000;Dogrukol-Ak et al 2004;Gozes and Furman 2004). The previous studies showed that VIP protects tissues from injury against several diseases including ischemia-reperfusion injury, sepsis, hemorrhage, colitis, asthma, rheumatoid arthritis, Parkinson disease, and Alzheimer's disease (Tikiz et al 1992;Said et al 1995;Erden et al 1998;Tunçel and Töre 1998;Tunçel et al 2000Tunçel et al , 2005Tore et al 2001;Can et al 2004;Szema et al 2006;Arranz et al 2008a, b).…”
Section: Introductionmentioning
confidence: 91%